XML 15 R4.htm IDEA: XBRL DOCUMENT v3.25.3
Interim Condensed Consolidated Statements of Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Income Statement [Abstract]        
Research and development, net $ (1,171) $ (2,060) $ (4,741) $ (4,646)
Sales, General and administrative (2,690) (1,240) (5,864) (3,549)
Operating loss (3,861) (3,300) (10,605) (8,195)
Other income (see Note 3G) 316
Financing income, net 284 85 611 144
Net loss $ (3,577) $ (3,215) $ (9,678) $ (8,051)
Basic net loss per share $ (0.07) $ (0.20) $ (0.25) $ (0.53)
Diluted net loss per share $ (0.07) $ (0.20) $ (0.25) $ (0.53)
Basic weighted average common shares outstanding 48,095,384 16,471,419 38,618,642 15,129,574
Diluted weighted average common shares outstanding 48,095,384 16,471,419 38,618,642 15,129,574